MARGARET ALISA DAVIS MD NPI 1811989411

NPI Details

Margaret Alisa Davis, MD is an internal medicine in Gainesville, GA with 33 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Margaret Alisa Davis, MD NPI is 1811989411. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: EMORY UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1993

The provider's business location address is:

725 JESSE JEWELL PKWY SE
GAINESVILLE, GA
ZIP 30501-834
Phone: (678) 207-4373
Fax: (770) 533-4727

The NPI 1811989411 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Hemoglobin a1c level (HCPCS:83036)
• Blood glucose (sugar) test performed by hand-held instrument (HCPCS:82962)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Sarscov2 vac 50mcg/0.25ml im (HCPCS:91306)
• Automated urinalysis test (HCPCS:81003)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Total protein level, urine (HCPCS:84156)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Coronavirus vaccine 14 (HCPCS:91313)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Vitamin d-3 level (HCPCS:82306)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Sarscov2 vac 30 mcg trs-sucr (HCPCS:91305)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Coronavirus vaccine 13 (HCPCS:91312)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Urine microalbumin (protein) level (HCPCS:82043)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use (HCPCS:91300)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Hepatitis c antibody screening, for individual at high risk and other covered indication(s) (HCPCS:G0472)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Lipase (fat enzyme) level (HCPCS:83690)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of vaccine (HCPCS:90471)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Creatine kinase (cardiac enzyme) level, mb fraction only (HCPCS:82553)
• Myoglobin (muscle protein) level (HCPCS:83874)
• Troponin (protein) analysis, quantitative (HCPCS:84484)
• Sarscov2 vac 50mcg/0.5ml im (HCPCS:91309)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Ferritin (blood protein) level (HCPCS:82728)
• Adm sarscov2 50 mcg/.5 mlbst (HCPCS:0094A)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Adm sarscv2 30mcg trs-sucr 3 (HCPCS:0053A)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)

The enumeration date for this NPI number is 8/19/2005 and was last updated on 4/12/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.